• Overview
• News & Insights
• Documents
• Multi-media

Investment Overview

Strategy Description

KPTL is raising Fund VI, with a focus on Americas’ HeathTech Market. This is an opportunity to leverage the more than 15 years of experience as one of the main investors in the HealtTech space in Latin America with a very targeted investment strategy aimed at solving some of the biggest challenges in the sector by bringing innovation and technology. We are going to create the leading platform of technology companies for the Heath sector in Latin America, driving strong return for investors and huge impact for local communities through a disciplined and seasoned investment process.

Principals

Danilo Zelinski - Head of Sales and IR, KPTL Ventures

Commentary

Above Average Returns

---

Investment Highlights

---

Investment Category

Venture Capital

Investment Strategy

Emerging Market, Early Stage, Venture Capital, HealthTech, BioTech, ESG

Implementation of Strategy

Tactical Approach

---

Investment Structure

---

Firm AUM

$200MM

Service Providers

---

ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.